5.900
+0,00%
2026-10-19
Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -173.9% | -36.1% | 2 / 3 | -3.8% | -68.37 pp | -65.00 pp | +5.5% | 0.27 | 8.57 | 19,3 | −3,8% | −5,4 | −173,9% | 8.57 | 7.98 | +7,4% |
| Pts | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 5.900 (close price on 2026-10-19)EPS (TTM): 688,2
Financial charts
1.Revenue & growth
VND bn19,3Q2/26
1.Revenue & growth
VND bn19,3Q2/26
2.Profit & growth
VND bn-5,44Q2/26
3.Profit mix (Penman)
VND bn31,1Q2/26
4.Margins & cost structure
%47.0%Q2/26
5.Returns & cash cycle
% · days5.9%Q2/26
6.Earnings quality & cash
VND bn56,5Q2/26
7.Asset structure
VND bn653Q2/26
8.Funding & debt health
VND bn · times653Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %8,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-134Q2/26
Adjusted EPS growth, latest quarter
-174%
Average adjusted EPS growth, 3 quarters
-36.1%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26